|
|
Henry Radziewicz, Richard M. Dunham, Arash Grakoui
J Clin Invest. 2009;
119(3):450
doi:10.1172/JCI38661
Abstract |
Full text
| PDF
A
daptive T cell responses are critical for controlling infections with viruses such as HIV, HBV, and HCV. However, these responses must be carefully regulated because overly vigorous T cell activation can lead to excessive host tissue damage. T cell expression of the inhibitory receptor programmed death–1 (PD-1) and inhibition of effector T cells (Teffs) by CD4+Foxp3+ Tregs are among the many described mechanisms for achieving a balanced immune response. Although the signals that contribute to Teff function are well understood, less is known about the signals controlling Tregs. In this issue of the JCI, Franceschini et al. extend our understanding of how Tregs are modulated during chronic HCV infection by demonstrating that Treg proliferation is inhibited by PD-1 and that this inhibition is mediated by a potentially novel mechanism involving the prevention of IL-2–driven STAT-5 phosphorylation (see the related article beginning on page 551).
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.
Tao Shen, Jiajia Zheng, Hua Liang, Chunhui Xu, Xiangmei Chen, Ting Zhang, Qiang Xu, Fengmin Lu
|
Virol J
|
2011 |
Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis
G. Thangavelu, J.C. Parkman, C.L. Ewen, R.R.E. Uwiera, T.A. Baldwin, C.C. Anderson
|
Journal of Autoimmunity
|
2011 |
Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function : Treg phenotype and function in HIV-1 infection
C. T. Burton, S. J. Westrop, I. Eccles-James, A. Boasso, M. R. Nelson, M. Bower, N. Imami
|
Clinical & Experimental Immunology
|
2011 |
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine
Christa Firbas, Thomas Boehm, Vera Buerger, Elisabeth Schuller, Nicolas Sabarth, Bernd Jilma, Christoph S. Klade
|
Vaccine
|
2010 |
Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome
L. R. V. Antonelli, Y. Mahnke, J. N. Hodge, B. O. Porter, D. L. Barber, R. DerSimonian, J. H. Greenwald, G. Roby, J. Mican, A. Sher, M. Roederer, I. Sereti
|
Blood
|
2010 |
Regulatory T cells in HIV immunotherapy
Bernard JC Macatangay, Charles R Rinaldo
|
HIV Therapy
|
2010 |
|